Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular Dystrophy

Authors

Teofil Ciobanu
Alexander P. Murphy (ORCID: https://orcid.org/0000-0003-4244-0541)
Ivana Audhya
Katherine Gooch (ORCID: https://orcid.org/0009-0000-6382-614X)
Eugenio Maria Mercuri (ORCID: https://orcid.org/0000-0002-9851-5365)
Fiona McDougall
Craig M. McDonald (ORCID: https://orcid.org/0000-0002-8779-3220)
Sai Dharmarajan (ORCID: https://orcid.org/0000-0002-9287-5810)
Jacob Elkins (ORCID: https://orcid.org/0009-0000-5898-8937)
Claire J. Lansdall

Institutions

Roche (Switzerland) (CH)
Centro Clinico Nemo (IT)
Roche (United Kingdom) (GB)
Sarepta Therapeutics (United States) (US)
Istituti di Ricovero e Cura a Carattere Scientifico (IT)

Publication Details

Journal: Neurology and Therapy
Published: 2024-11-26
DOI: https://doi.org/10.1007/s40120-024-00685-8
Citations: 4
Primary Topic: Muscle Physiology and Disorders
Type: article
Field-Weighted Citation Impact: 0.94

Funders

F. Hoffmann-La Roche
Sarepta Therapeutics

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular Dystrophy

Teofil Ciobanu, Alexander P. Murphy, Ivana Audhya, Katherine Gooch et al.

Nov 26, 2024

4 citations

Neurology and Therapy

Muscle Physiology and Disorders

0.94

article

Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular Dystrophy

Teofil Ciobanu, Alexander P. Murphy, Ivana Audhya, Katherine Gooch, Eugenio Maria Mercuri, Fiona McDougall, Craig M. McDonald, Sai Dharmarajan, Jacob Elkins, Claire J. Lansdall

November 26, 2024article en

4 citations

Abstract

No abstract available for this paper.

Neurology and TherapyVol. 14(1)

Roche (Switzerland) (CH), Centro Clinico Nemo (IT), Roche (United Kingdom) (GB), Sarepta Therapeutics (United States) (US), Istituti di Ricovero e Cura a Carattere Scientifico (IT)

F. Hoffmann-La Roche, Sarepta Therapeutics

Openalex Percentile: Top 25%

Muscle Physiology and Disorders

0.94

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular Dystrophy — Teofil Ciobanu, Alexander P. Murphy, et al. · Neurology and Therapy (2024) | TGRS Research Map | TGRS